| Celiac Disease |
1 |
1 |
| Refractory Celiac Disease |
0 |
0.99 |
| Diet |
0 |
0.4 |
| Refractory |
0 |
0.4 |
| Lymphoma |
0 |
0.32 |
| Lymphocytes |
0 |
0.24 |
| Malnutrition |
0 |
0.24 |
| Steroids |
0 |
0.24 |
| Wireless Capsule Endoscopy |
0 |
0.17 |
| CT Scan |
0 |
0.16 |
| Endoscopy |
0 |
0.16 |
| Malabsorption |
0 |
0.16 |
| Prognosis |
0 |
0.16 |
| Referral |
0 |
0.16 |
| Inflammatory Bowel Disease |
0 |
0.12 |
| T-Cell Receptor |
0 |
0.11 |
| Adverse Effects |
0 |
0.08 |
| Biopsy |
0 |
0.08 |
| Board Certification |
0 |
0.08 |
| Clinical Research |
0 |
0.08 |
| Colitis |
0 |
0.08 |
| Duodenum |
0 |
0.08 |
| Esophagogastroduodenoscopy (EGD) |
0 |
0.08 |
| Flow Cytometry |
0 |
0.08 |
| Fructose 1-Phosphate Aldolase Deficiency |
0 |
0.08 |
| Glucocorticoid |
0 |
0.08 |
| Grant |
0 |
0.08 |
| Immunodeficiency |
0 |
0.08 |
| Immunoglobulin A (IgA) |
0 |
0.08 |
| Immunoglobulin G (IgG) |
0 |
0.08 |
| Immunohistochemistry |
0 |
0.08 |
| Multidisciplinary Team |
0 |
0.08 |
| New York |
0 |
0.08 |
| Receptors |
0 |
0.08 |
| Serology |
0 |
0.08 |
| Small Intestine |
0 |
0.08 |
| Tissue |
0 |
0.08 |
| Tropical Diseases |
0 |
0.08 |
| Tropical Sprue |
0 |
0.08 |
| Biologic Therapy |
0 |
0.06 |
| Healthcare and Medical Technology |
0 |
0.06 |
| Irritable Bowel Syndrome |
0 |
0.06 |
| Patient Safety |
0 |
0.06 |